Back to mobile site

InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c

February 13, 2025 4:08 AM EST

InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK